Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Mauri

Showing results (141-150 of 335) with videos related to

Pageof 34
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 6, 2013
Long-term efficacy and safety of Zotarolimus-eluting stent in patients with diabetes mellitus: pooled 5-year results from the ENDEAVOR III and IV trialsMoshe Vardi, David A Burke, Sripal Bangalore, et al.
Circulation. Cardiovascular Quality and Outcomes|November 21, 2013
Instrumental variable analysis to compare effectiveness of stents in the extremely elderlyRobert W Yeh, Samip Vasaiwala, Daniel E Forman, et al.
Lancet (London, England)|December 4, 2014
Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysisSammy Elmariah, Laura Mauri, Gheorghe Doros, et al.
American Heart Journal|July 7, 2020
Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II)Natalia Berry, Laura Mauri, Ted Feldman, et al.
American Heart Journal|July 6, 2010
The EVEREST II Trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitationLaura Mauri, Pallav Garg, Joseph M Massaro, et al.
Circulation|October 15, 2008
Long-term clinical outcomes after drug-eluting and bare-metal stenting in MassachusettsLaura Mauri, Treacy S Silbaugh, Robert E Wolf, et al.
Circulation|January 24, 2008
Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patientsAlanna Coolong, Donald S Baim, Richard E Kuntz, et al.
Journal of Neurochemistry|February 19, 2019
GM1 promotes TrkA-mediated neuroblastoma cell differentiation by occupying a plasma membrane domain different from TrkAElena Chiricozzi, Erika Di Biase, Margherita Maggioni, et al.
Journal of Lipid Research|November 25, 2014
Direct interaction, instrumental for signaling processes, between LacCer and Lyn in the lipid rafts of neutrophil-like cellsElena Chiricozzi, Maria Grazia Ciampa, Giuseppina Brasile, et al.
American Heart Journal|January 28, 2019
Design and rationale of a randomized noninferiority trial to evaluate the SurVeil drug-coated balloon in subjects with stenotic lesions of the femoropopliteal artery - the TRANSCEND studySammy Elmariah, Gary M Ansel, Marianne Brodmann, et al.
Pageof 34

Showing results (141-150 of 335) with videos related to

Sort By:
Pageof 34
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 6, 2013
Long-term efficacy and safety of Zotarolimus-eluting stent in patients with diabetes mellitus: pooled 5-year results from the ENDEAVOR III and IV trialsMoshe Vardi, David A Burke, Sripal Bangalore, et al.
Circulation. Cardiovascular Quality and Outcomes|November 21, 2013
Instrumental variable analysis to compare effectiveness of stents in the extremely elderlyRobert W Yeh, Samip Vasaiwala, Daniel E Forman, et al.
Lancet (London, England)|December 4, 2014
Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysisSammy Elmariah, Laura Mauri, Gheorghe Doros, et al.
American Heart Journal|July 7, 2020
Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II)Natalia Berry, Laura Mauri, Ted Feldman, et al.
American Heart Journal|July 6, 2010
The EVEREST II Trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitationLaura Mauri, Pallav Garg, Joseph M Massaro, et al.
Circulation|October 15, 2008
Long-term clinical outcomes after drug-eluting and bare-metal stenting in MassachusettsLaura Mauri, Treacy S Silbaugh, Robert E Wolf, et al.
Circulation|January 24, 2008
Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patientsAlanna Coolong, Donald S Baim, Richard E Kuntz, et al.
Journal of Neurochemistry|February 19, 2019
GM1 promotes TrkA-mediated neuroblastoma cell differentiation by occupying a plasma membrane domain different from TrkAElena Chiricozzi, Erika Di Biase, Margherita Maggioni, et al.
Journal of Lipid Research|November 25, 2014
Direct interaction, instrumental for signaling processes, between LacCer and Lyn in the lipid rafts of neutrophil-like cellsElena Chiricozzi, Maria Grazia Ciampa, Giuseppina Brasile, et al.
American Heart Journal|January 28, 2019
Design and rationale of a randomized noninferiority trial to evaluate the SurVeil drug-coated balloon in subjects with stenotic lesions of the femoropopliteal artery - the TRANSCEND studySammy Elmariah, Gary M Ansel, Marianne Brodmann, et al.
Pageof 34